Biocatalysts.
Abstract
Production of enzyme-containing biocatalysts by a method in which whole cells of enzyme-containing microorganisms are spray dried under conditions such that the biocatalytic activity of the enzymes is retained. The method may be used to produce biocatalysts containing in particular the enzymes cyanide hydratase, amidase and D-2-haloalkanoic acid halidohydrolase. Biocatalysts per se and a process in which they are used for conducting a biochemical reaction are also claimed.

Term
Term ended
Projected expiry passed 11 October 2009, 17 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
10 claims: 3 independent, 7 dependent
- 1Enzyme-containing biocatalysts which have been produced by spray drying whole cells of enzyme-containing microorganisms under conditions such that the biocatalytic activity of the enzymes is retained.
- 2A method for the production of enzyme-containing biocatalysts which comprises a step wherein whole cells of enzyme-containing microorganisms are spray dried under conditions such that the biocatalytic activity of the enzymes is retained.
- 9A process for conducting a biochemical reaction in which an enzyme-containing biocatalyst is used wherein the enzyme containing biocatalyst has been produced by spray drying whole cells of an enzyme-containing microorganism under conditions such that the biocatalytic activity of the enzyme is retained.
Independent claims3
21 paragraphs in 5 sections, as filed
This invention relates to biocatalysts, to a method for their production and to a biochemical process using such biocatalysts.
The microbiological sciences have developed rapidly during the past two decades and an increasing number of commercial biochemical processes have been developed using enzymes as biocatalysts. Examples of such biochemical processes include those described in our European Patent Specifications Nos. 76606 and 179603. In such processes the biocatalysts employed have an important role.
To date enzymes used as biocatalysts have generally been used in the forms; (a) purified enzymes; (b) wet suspensions of cells containing the enzymes; and (c) immobilised whole cells containing the enzymes. All three forms however have disadvantages which restrict their commercial applicability. Purified enzymes are very useful but are expensive to produce and their utility is restricted to processes producing high-value end products. Enzymes in wet cell suspensions lose their activity quickly. When such suspensions are to be stored even for short periods it is necessary to add other materials such as anti-freeze cryo-protectants to them and to cool to temperatures below 0<sup>o</sup>C to prevent rupture of cells contained in the suspensions. With enzymes in immobilised whole cells it is difficult to maintain the full activity of the enzymes over long periods.
According to the present invention we provide enzyme-containing biocatalysts which have been produced by spray drying whole cells of enzyme-containing microorganisms under conditions such that the biocatalytic activity of the enzymes is retained.
Further according to the present invention we provide a method for the production of enzyme-containing biocatalysts which comprises a step wherein whole cells of enzyme-containing microorganisms are spray dried under conditions such that the biocatalytic activity of the enzymes is retained.
Further according to the present invention we provide a process for conducting a biochemical reaction in which an enzymecontaining biocatalyst is used wherein the enzyme containing biocatalyst has been produced by spray drying whole cells of an enzymecontaining microorganism under conditions such that the biocatalytic activity of the enzyme is retained.
A general feature of soluble proteins is that an irreversible denaturation occurs with loss of enzyme activity at higher temperatures. For any enzyme there is a temperature above which enzyme activity is rapidly lost. Thus for example many dehalogenase enzymes become inactive when the temperatures of solutions containing them rise above 50<sup>o</sup>C. It is therefore surprising that spray dried microorganisms can retain biocatalytic activity and spray drying techniques have not previously been used upon microorganism cells intended for use as biocatalysts. We believe that the retention of biocatalytic activity occurs because, although the temperatures used in spray drying are much higher than those at which inactivation normally occurs, the residence time of the cells at these high temperatures is short and in consequence the degree of inactivation is insignificant.
The method of the invention can be used to produce biocatalysts using yeasts or bacteria (particularly Gram-negative bacteria) and including strains produced by genetic modification. Biocatalysts can be produced containing any required enzyme. Enzymes which can very suitably be contained in the biocatalysts of the invention include cyanide hydratase, amidase, alcohol dehydrogenases and D-2-haloalkanoic acid halidohydrolase (D-2-HAA halidohydrolase). In particular the method of the invention may be used for the production of biocatalysts for use in the process of our European Patent Specification No. 179603 by spray drying cells of the following bacterial strains:- <ul id="ul0001" list-style="none"><li>1. <u style="single">Pseudomonas putida</u> NCIB 12018</li><li>2. <u style="single">Pseudomonas fluorescens</u> NGIB 12159</li><li>3. NCIB 12160</li><li>4. NCIB 12161</li><li>5. <u style="single">Pseudomonas putida</u> NCIB 12158.</li></ul> Cultures of these strains have been deposited at The National Collections of Industrial and Marine Bacteria (NCIMB), PO Box 31, 135 Abbey Road, Aberdeen, UK.
Other commercially useful microorganism whose cells may be spray dried by the method of the invention include the following:- <u style="single">Fusarium lateritium</u> Nees strain CMI 300533 described in EP 233719 and deposited, 3 February 1986, at the Commonwealth Mycological Institute (CMI), Ferry Lane, Kew, Richmond, Surrey, England; <u style="single">Methylophilus methylotrophus</u> strain AS-1 (NCIB 10515) described in GB 1370892; <u style="single">Candida utilis</u> strain ATCC 8206 deposited at the American Type Culture Collection (ATCC), 12301 Parklawn Drive, Rockville, Maryland, 20852, USA; and <u style="single">Lactobacillus plantarum</u> strain NCIMB 40027
In spray drying a feed (usually aqueous) is atomized into a spray which is contacted with a drying medium (generally air) to cause moisture evaporation. Drying of the spray continues until the desired moisture content in the dried particles is obtained at which stage the product is recovered from the drying medium. The method of the invention can be carried out using any spray drying technique, e.g. using a pressure nozzle, a rotary atomiser or a two-fluid nozzle. Preferred spray drier inlet temperatures are in the range 140<sup>o</sup>C to 250<sup>o</sup>C, particularly in the range 140<sup>o</sup>C to 180<sup>o</sup>C. Preferred spray drier outlet temperatures are in the range 60<sup>o</sup>C to 110<sup>o</sup>C, particularly in the range 60<sup>o</sup>C to 90<sup>o</sup>C. It is preferred that spray drying is conducted in such a way that the period during which the cells are subjected to high temperatures is as brief as possible consistant with satisfactory drying being effected. Suitable average periods of exposure to higher temperatures are in the range 15 seconds to 45 seconds. The method of the invention is preferably applied to cell-containing suspensions with cell dry weights in the range 2% to 18%, particularly 6% to 12%.
The method of the invention can be carried out on a batch or continuous basis. The spray drying may be either a distinct process, carried out on cells produced in another process elsewhere, or a step in an overall process wherein the microorganism cells are supplied to the spray drier as they are produced in a fermenter and are thereafter harvested. The process of the invention may be applied in a wide variety of biochemical processes. In particular it can be applied in the process of our European Patent Specification No. 179603. The process of European Specification 179603 increases the concentration of the L-enantiomer of a 2- haloalkanoic acid in a mixture of the D- and L- enantiomers.
Spray dried cells produced by the method of the invention generally retain their enzyme activity for considerably longer periods than is the case with conventional wet cell suspensions. In particular spray dried cells can be stored for periods up to a year with negligible loss of activity. In contrast enzyme activity in wet cell suspensions declines steadily with time and becomes negligible after periods of only a few weeks, e.g. four to six weeks.
The method of the invention is illustrated in the accompanying Figure which is a diagram of an apparatus for open-cycle, co-current spray drying.
In the apparatus of the Figure a feed, comprising an aqueous suspension of microrganism cells containing the enzyme biocatalyst to be produced, and heated air are supplied along conduits 1 and 2 respectively to atomizer 3 in which the feed is atomised into a fine spray containing millions of individual droplets. Atomizer 3 is located in the upper end of drying chamber 4 and after the spray has been produced it passes into the drying chamber 4 and is dried. Following drying of the spray the majority of the dried product falls into the lower part 5 of drying chamber 4. The product fines remain entrained in tile air and pass along exhaust drying air duct 6 to powder recovery cyclone 7 for separation. Thereafter the fines enter the pneumatic conveying system. From the lower part 5 of drying chamber 4 the majority of the product passes through powder take-off 8 into conduit 9 along which it is carried by conveying air, supplied from 10, to transport cyclone 11. The dried product (dried microorganism cells containing active enzyme biocatalyst) is finally removed from the apparatus at the lower end 12 of transport cyclone 11. Exhaust air from cyclones 7 and 11 passes to the atmosphere through scrubber 13.
The invention is illustrated by the following Examples:-
EXAMPLE 1
The apparatus shown in the Figure was used to spray dry cells of the bacterium <u style="single">Pseudomonas putida</u> NCIB 12018 containing the enzyme D-2-haloalkanoic acid halidohydrolase. The spray drier inlet temperature was 180<sup>o</sup>C and the outlet temperature was 90<sup>o</sup>C. The retention of activity of the enzyme in hydrolysing D-chloropropionic acid to L-lactic acid over the spray drier was found to be 100%.
In storage it was found that the spray dried cells would retain 50% of the enzyme activity after six months on storage at room temperature. Enzyme activity was completely retained in storage for over 12 months at 4<sup>o</sup>C and -20<sup>o</sup>C. This compares most favourably with the retention of activity by wet cells of the same microorganism. In the wet cells activity was lost within 3 weeks at 4<sup>o</sup>C.
EXAMPLE 2
The apparatus shown in the Figure was used to spray dry cells of the fungus <u style="single">Fusarium lateritium</u> Nees containing the enzyme cyanide hydratase. The spray drier inlet temperature was 150<sup>o</sup>C and the outlet temperature was 70<sup>o</sup>C. The retention of activity of the enzyme in degrading cyanide to formamide over the drier was found to be 100%. In storage it was found that the spray dried cells retained enzyme activity for several months. This compares most favourably with the retention of activity by wet cells of the same microorganism. In the wet cells activity was lost in 7 days.
EXAMPLE 3
The apparatus shown in the Figure was used to spray dry cells of the bacterium <u style="single">Methylophilus methylotrophus</u> strain AS-1 (NCIB 10515) containing the enzyme amidase. The spray drier inlet temperature was 160<sup>o</sup> to 180<sup>o</sup>C and the outlet temperature was 80<sup>o</sup> to 90<sup>o</sup>C. The retention of activity of the enzyme in the decomposition of acrylamide over the drier was found to be 90%. In storage it was found that the spray dried cells retained enzyme activity for several months. This compares most favourably with the retention of activity by wet cells of the same microorganism. In the wet cells activity was lost in 7 days.
EXAMPLE 4
The apparatus shown in the Figure was used to spray dry cells of the yeast <u style="single">Candida utilis</u> Strain ATCC 8206 containing the enzyme pyruvate decarboxylase. The spray drier inlet temperature was 150<sup>o</sup>C and the outlet temperature was 60<sup>o</sup>C. The retention of activity of the enzyme pyruvate decarboxylase over the drier was found to be 80%. The period of time for which enzyme activity was retained in storage was found to be similar to the period for which activity was retained in wet cells of the same microorganism.
EXAMPLE 5
The apparatus of the Figure was used to spray dry cells of the bacterium <u style="single">Lactobacillus plantarum</u> strain NCIB 40027. The spray drier inlet temperature was 150<sup>o</sup>C and the outlet temperature was 70<sup>o</sup>C. The retention of activity by the bacterial cells in the glycolitic pathway and in amino acid biosynthesis over the drier was 100%. In storage it was found that the spray dried cells retained activity in the above metabolic pathways for several months. This compares most favourably with the retention of activity by wet cells of the same microorganism. In the wet cells activity was lost in 1 to 2 weeks.
Contents5
2 sheets
Sheet 1 Sheet 2
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US10398648B2 | Cited by | United States of America | Applicant |
| CN100378218C | Cited by | China | Search report |
| US6146879A | Cited by | United States of America | Search report |
| US6924133B1 | Cited by | United States of America | Applicant |
| US6426210B1 | Cited by | United States of America | Applicant |
| US6825031B2 | Cited by | United States of America | Applicant |
| WO0125411A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US5928469A | Cited by | United States of America | Search report |
| EP1640451A1 | Cited by | European Patent Office (EPO) | Search report |
| EP0179603A2 | Cites | European Patent Office (EPO) | Search report |
| DE2626626A | Cites | Germany | Search report |
13 members in 8 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 8824897 | United Kingdom | A | |
| 8824897 | United Kingdom | – | |
| 8824897 | – | – | – |
| GB19880024897 | – | – | – |
Members13
| Document | Office | Kind | |
|---|---|---|---|
| GB8824897D0 | United Kingdom | D0 | |
| CA2001115A1 | Canada | A1 | |
| AU4361889A | Australia | A | |
| EP0366303A2This record | European Patent Office (EPO) | A2 | |
| JPH02171184A | Japan | A | |
| EP0366303A3 | European Patent Office (EPO) | A3 | |
| EP0366303B1 | European Patent Office (EPO) | B1 | |
| AT131529T | Austria | T | |
| DE68925097D1 | Germany | D1 | |
| DE68925097T2 | Germany | T2 | |
| JP2901286B2 | Japan | B2 | |
| US6146879A | United States of America | A | |
| CA2001115C | Canada | C |
48 legal events, as 4 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Nl: ceased due to reaching the maximum lifetime of a patentCeasedNLV7 | NLV7 | EP | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Be: patent expiredExpiredBE20 | BE20 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)732E | 732E | GB | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)732E | 732E | GB | |
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| New agentNV | NV | CH | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Transmission of propertyTP | TP | FR | |
| Nl: assignments of ep-patentsNLS | NLS | EP | |
| Nl: modifications of names registered in virtue of documents presented to the patent office pursuant to art. 16 a, paragraph 1NLT1 | NLT1 | EP | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| Be: change of holder's address20010822 *AVECIA LTD:HEXAGON HOUSE, BLACKLEY MANCHESTER M9 8ZSBECA | BECA | EP | |
| Be: change of holder20010822 *AVECIA LTDBECH | BECH | EP | |
| Name/firm changedZENECA LIMITED TRANSFER- SYNGENTA LIMITEDPFA | PFA | CH | |
| AssignmentPUE | PUE | CH | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)732E | 732E | GB | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Fr: translation filedET | ET | EP | |
| New agentNV | NV | CH | |
| Corresponds to:REF | REF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Designated contracting statesAK | AK | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0366303
- Publication, DOCDB
- 0366303
- Publication, EPODOC
- EP0366303
- Application
- 89310397
- Application, DOCDB
- 89310397
- Application, EPODOC
- EP19890310397
Titles3
- German
- Biokatalysatoren
- English
- Biocatalysts
- French
- Biocatalyseurs
Classification
- CPC, 5
- C12N9/88
- C12N1/005
- C12N9/14
- C12N9/78
- C12P41/00
- IPC, 8
- C12P1 00
- C12N1 00
- C12N9 00
- C12N9 14
- C12N9 78
- C12N9 80
- C12N9 88
- C12P41 00
Designated states10
- Contracting states, 10
- Austria
- Belgium
- Switzerland
- Germany
- France
- United Kingdom
- Italy
- Liechtenstein
- Netherlands (Kingdom of the)
- Sweden